Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
News

Pandemic preparedness: begin at the source

Barbara Sibbald
CMAJ November 22, 2005 173 (11) 1309-1310; DOI: https://doi.org/10.1503/cmaj.051411
Barbara Sibbald
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Farm surveillance, along with fair compensation for producers who have to kill infected fowl, is the essential front-line of defence against an avian influenza pandemic, agreed health ministers from 30 countries and heads of 8 international agencies, including the WHO, at a conference in Ottawa.

Figure

Figure. A Romanian police officer helps cull a flock of domestic ducks with Avian flu. In October, the flu also hit fowl in Russia and Turkey, Croatia and Greece. Photo by: Canapress

Avian flu is concentrated in developing countries where farmers can ill afford to kill their flocks; so far, 140 million ducks and chickens have been slaughtered in Asia, at a cost of $10 billion. Farmers are compensated in most countries, but not to the full extent of their loss, giving them little incentive to report the disease.

As of Oct. 26, Avian flu H5N1 had infected 100 people, killing 62, in 4 Asian countries; most died after direct contact with infected birds. But experts fear that with continued human exposure to infected birds the virus could mutate into a form easily transmitted among people.

We need to “double and redouble our efforts to stop avian influenza at its source, in animals,” said Jacques Diouf, director general of the Food and Agriculture Organization (FAO) at the Oct. 24–25 conference on Global Pandemic Influenza Readiness in Ottawa.

These efforts would include both fair compensation for farmers and science-based systems for raising poultry and marketing live birds.

“We must take prudent measures … to stop this disease in its tracks,” he said. “It can be done.”

No concrete initiatives stemmed from the 2-day meeting, but participants stated in a Communiqué that it was an “important step” toward a long-term sustained political and institutional engagement. They identified a huge number of needs, including a harmonized global approach to research and development, along with increased production capacity, access and distribution of vaccine and antiviral agents.

Mexico's call for developed nations to reserve 10% of antivirals for poorer nations was put aside. Instead, the ministers decided it might be more appropriate for the 10 or so countries that have adequate supplies of the drugs, including Canada, to develop a way to share, such as through the WHO stockpile.

Only about 40 countries are ready for a pandemic, said Dr. Jong-wook Lee, Director General of WHO. “We must help countries stockpile.”

Roche International, the manufacturer of oseltamivir (Tamiflu), has promised WHO 30 million capsules of oseltamivir to cover 3 million people; enough for 1 million has been delivered.

The best protection, Lee added, is an effective vaccine, but that can't be developed until a human strain emerges, after which a vaccine will take months to produce. There is also insufficient global manufacturing capacity to produce the quantities needed. “It's a huge challenge,” he said. “We need investment.”

Delegates also agreed that coodinated risk communications among countries and institutions is needed to avoid public panic.

It may already be too late. In the midst of the conference, Roche Canada decided to temporarily stop shipping oseltamivir to private pharmacies in face of an unprecedented demand and fears of dwindling stock. In September, about 4000 prescriptions for the drug were filled for Canadians, compared to 421 in September 2004.

A Nov 7–9 international meeting on avian and pandemic influenza will “bring concerns to the next stage,” said Lee.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 173 (11)
CMAJ
Vol. 173, Issue 11
22 Nov 2005
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pandemic preparedness: begin at the source
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Pandemic preparedness: begin at the source
Barbara Sibbald
CMAJ Nov 2005, 173 (11) 1309-1310; DOI: 10.1503/cmaj.051411

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Pandemic preparedness: begin at the source
Barbara Sibbald
CMAJ Nov 2005, 173 (11) 1309-1310; DOI: 10.1503/cmaj.051411
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Saying goodbye to CMAJ News
  • National survey highlights worsening primary care access
  • How Canadian hospitals are decreasing carbon emissions
Show more News

Similar Articles

Collections

  • Topics
    • Global health
    • Infectious diseases

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire